MDMA assisted therapy: Three papers are retracted as FDA rejects PTSD application
BMJ 2024; 386 doi: https://doi.org/10.1136/bmj.q1798 (Published 13 August 2024) Cite this as: BMJ 2024;386:q1798- Elisabeth Mahase
- The BMJ
Three research papers on MDMA assisted psychotherapy have been retracted by the journal Psychopharmacology because of “protocol violations amounting to unethical conduct” by researchers at a study site.
In the retraction notices the journal said that the authors were aware of the violations when they submitted the articles but failed to disclose them or remove the affected data from their analysis.123 All three papers related to phase 2 randomised controlled trials for MDMA assisted therapy, with similar authors listed for all three papers.
The …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.